Cargando…
Preferential translation of p53 target genes
The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993080/ https://www.ncbi.nlm.nih.gov/pubmed/35388737 http://dx.doi.org/10.1080/15476286.2022.2048562 |
_version_ | 1784683840228294656 |
---|---|
author | Hisaoka, Miharu Schott, Johanna Bortecen, Toman Lindner, Doris Krijgsveld, Jeroen Stoecklin, Georg |
author_facet | Hisaoka, Miharu Schott, Johanna Bortecen, Toman Lindner, Doris Krijgsveld, Jeroen Stoecklin, Georg |
author_sort | Hisaoka, Miharu |
collection | PubMed |
description | The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including translational inhibition of ribosomal protein synthesis and translational activation of MDM2. A challenge in the analysis of translational control is that changes in mRNA abundance exert a kinetic (passive) effect on ribosome densities. In order to separate these passive effects from active regulation of translation efficiency in response to p53 activation, we conducted a comprehensive analysis of translational regulation by comparative analysis of mRNA levels and ribosome densities upon DNA damage induced by neocarzinostatin in wild-type and TP53(−/−) HCT116 colorectal carcinoma cells. Thereby, we identified a specific group of mRNAs that are preferentially translated in response to p53 activation, many of which correspond to p53 target genes including MDM2, SESN1 and CDKN1A. By subsequent polysome profile analysis of SESN1 and CDKN1A mRNA, we could demonstrate that p53-dependent translational activation relies on a combination of inducing the expression of translationally advantageous isoforms and trans-acting mechanisms that further enhance the translation of these mRNAs. |
format | Online Article Text |
id | pubmed-8993080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89930802022-04-09 Preferential translation of p53 target genes Hisaoka, Miharu Schott, Johanna Bortecen, Toman Lindner, Doris Krijgsveld, Jeroen Stoecklin, Georg RNA Biol Research Paper The transcription factor p53 exerts its tumour suppressive effect through transcriptional activation of numerous target genes controlling cell cycle arrest, apoptosis, cellular senescence and DNA repair. In addition, there is evidence that p53 influences the translation of specific mRNAs, including translational inhibition of ribosomal protein synthesis and translational activation of MDM2. A challenge in the analysis of translational control is that changes in mRNA abundance exert a kinetic (passive) effect on ribosome densities. In order to separate these passive effects from active regulation of translation efficiency in response to p53 activation, we conducted a comprehensive analysis of translational regulation by comparative analysis of mRNA levels and ribosome densities upon DNA damage induced by neocarzinostatin in wild-type and TP53(−/−) HCT116 colorectal carcinoma cells. Thereby, we identified a specific group of mRNAs that are preferentially translated in response to p53 activation, many of which correspond to p53 target genes including MDM2, SESN1 and CDKN1A. By subsequent polysome profile analysis of SESN1 and CDKN1A mRNA, we could demonstrate that p53-dependent translational activation relies on a combination of inducing the expression of translationally advantageous isoforms and trans-acting mechanisms that further enhance the translation of these mRNAs. Taylor & Francis 2022-04-07 /pmc/articles/PMC8993080/ /pubmed/35388737 http://dx.doi.org/10.1080/15476286.2022.2048562 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Hisaoka, Miharu Schott, Johanna Bortecen, Toman Lindner, Doris Krijgsveld, Jeroen Stoecklin, Georg Preferential translation of p53 target genes |
title | Preferential translation of p53 target genes |
title_full | Preferential translation of p53 target genes |
title_fullStr | Preferential translation of p53 target genes |
title_full_unstemmed | Preferential translation of p53 target genes |
title_short | Preferential translation of p53 target genes |
title_sort | preferential translation of p53 target genes |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993080/ https://www.ncbi.nlm.nih.gov/pubmed/35388737 http://dx.doi.org/10.1080/15476286.2022.2048562 |
work_keys_str_mv | AT hisaokamiharu preferentialtranslationofp53targetgenes AT schottjohanna preferentialtranslationofp53targetgenes AT bortecentoman preferentialtranslationofp53targetgenes AT lindnerdoris preferentialtranslationofp53targetgenes AT krijgsveldjeroen preferentialtranslationofp53targetgenes AT stoecklingeorg preferentialtranslationofp53targetgenes |